Moximed’s MISHA Knee Achieves Superiority of Primary Endpoint in Pivotal Study

Results from the pivotal Calypso Study of Moximed's MISHA™ Knee System, an implantable shock absorber (ISA) for the treatment of knee osteoarthritis, demonstrated superiority of the primary endpoint and demonstrated a clinically significant reduction in pain scores and improvement in function scores for participants receiving the MISHA Knee.

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us